Abstract
The effect of the selective serotonin uptake inhibitor fluoxetine was examined on prodynorphin gene expression. Fluoxetine or vehicle was infused continuously for 7 d via osmotic minipumps into male rats. Northern blot analysis showed significant increases in prodynorphin gene expression in the hypothalamus (171% of controls) and significant decreases in the caudate putamen and nucleus accumbens (62% and 70% of controls, respectively). There were no significant changes in the hippocampus. Thus, chronic inhibition of serotonin uptake can regulate prodynorphin gene expression in the hypothalamus, caudate putamen, and nucleus accumbens. Fluoxetine effects were also evaluated in rats treated with p-chloroamphetamine (PCA), a neurotoxin that depletes serotonin. Because we previously reported that continuous infusion of cocaine for 7 d (which inhibits dopamine, serotonin, and norepinephrine uptake), or GBR 12909 (a selective dopamine uptake inhibitor), produced significant decreases in the hypothalamus and cocaine also produced a significant increase in prodynorphin gene expression in caudate putamen, regulation of prodynorphin gene expression by fluoxetine is suggested to be different from that by cocaine. Because neither a selective dopamine uptake inhibitor nor a selective serotonin uptake inhibitor produced the same effect as cocaine in the caudate putamen, this effect is likely regulated by the inhibition of norepinephrine uptake, by a combination of effects on two or three neurotransmitter transporters, or by a mechanism unrelated to transporter inhibition.
Similar content being viewed by others
References
Baker D. A., Tran-Nguyen T. L., Fuchs R. A., and Neisewander J. L. (2001) Influence of individual differences and chronic fluoxetine treatment on cocaine-seeking behavior in rats. Psychopharmacology (Berl.) 155, 18–26.
Bymaster F. P., Zhang W., Carter P. A., Shaw J., Chernet E., Phebus L., et al. (2002) Fluoxetine, but not other selective serotonin uptake inhibitors, increase norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berl.) 160, 353–361.
Carroll M. E., Lac S. T., Asencio M., and Kragh R. (1990) Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 35, 237–244.
Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156–159.
Civelli O., Douglass J., Goldstein A., and Herbert E. (1985) Sequence and expression of the rat prodynorphin gene. Proc. Natl. Acad. Sci. USA 82, 4291–4295.
Collins S. L., Kunko P. M., Ladenheim B., Cadet J. L., Carroll F. I. and Izenwasser S. (2002) Chronic cocaine increases kappa-opioid receptor density: lack of effect by selective dopamine uptake inhibitors. Synapse 45, 153–158.
Daunais J. B. and McGinty J. F. (1995) Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs. Brain Res. Mol. Brain Res. 29, 201–210.
Daunais J. B., Hart S. L., Hedgecock-Rowe A., Matasi J. J., Thornley C., Davies H. M. L., and Porrino L. J. (1997) Alterations in behavior and opioid gene expression induced by the novel tropane analog WF-31. Brain Res. Mol. Brain Res. 50, 3293–3304.
Daunais J. B., Roberts D. C. S., and McGinty J. E. L. (1993) Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. NeuroReport 4, 543–546.
Gunning P., Ponte P., Okayama H., Engel J., Blau H., and Kedes L. (1983) Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol. Cell Biol. 3, 787–795.
Hall F. S., Li X. F., Sora I., Xu F., Caron M., Lesch K. P., et al. (2002) Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neuroscience 115, 153–161.
Herve D., Pickel V. M., Joh T. H., and Breaudet A. (1987) Serotonin axon terminals in the ventral tegmental area of the rat fine structure and synaptic input to dopaminergic neurones. Brain Res. 453, 71–83.
Hurd Y. L. and Herkenham M. (1992) Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Mol. Brain Res. 16, 97–104.
Izenwasser S., French D., Carroll F. I., and Kunko P. M. (1999) Continuous infusion of selective dopamine uptake inhibitors or cocaine produces time-dependent changes in rat locomotor activity. Behav. Brain Res. 99, 201–208.
Izenwasser S., Heller B., and Cox B. M. (1996) Continuous cocaine administration enhances μ- but not σ-opioid receptor-mediated inhibition of adenylyl cyclase activity in nucleus accumbens. Eur. J. Pharmacol. 297, 187–191.
Koch S., Perry K. W., Nelson D. L., Conway R. G., Threlkeld P. G., and Bymaster F. P. (2002) R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study. Neuropsychopharmacology 27, 949–959.
Kondo Y., Ogawa N., Asanuma M., Hirata K., Tanaka K., Kawada Y., and Mori, A. (1993) Regional changes in neuropeptide levels after 5,7-dihydroxytryptamine-induced serotonin in the rat brain. J. Neural Transm. Gen. Sect. 92, 151–157.
Kunko P. M., Loeloff R. J., and Izenwasser S. (1997) Chronic administration of GBR 12909, but not cocaine, produces marked decreases in dopamine transporter density. Naunyn-Schmiedeberg’s Arch. Pharmacol. 356, 562–569.
Lee K. and Kornetsky C. (1998) Acute and chronic fluoxetine treatment decreases the sensitivity of rats to rewarding brain stimulation. Pharmacol Biochem Behav. 60, 539–544.
Lucas J. J., Mellstrom B., Colado M. I., and Naranjo J. R. (1993) Molecular mechanisms of pain: serotonin 1A receptor agonists trigger transactivation by c-fos of the prodynorphin gene in spinal cord neurons. Neuron 10, 599–611.
Maniatis T., Fritsch E. F., and Sambrook J., eds. (1982) Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Mathieu-Kia A. and Besson M., (1998) Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat. Mol. Brain Res. 54, 141–151.
Matsumoto M., Togashi H., Mori K., Veno K., Miyamoto A., and Yoshioka M. (1999) Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex. Eur. J. Pharmacol. 383, 39–48.
Mcmahon L. R. and Cunningham K. A. (2001) Antagonism of 5-hydroxytryptamine2A receptors attenuates the behavioral effects of cocaine in rats. J. Pharmacol. Exp. Ther. 297, 357–363.
Peltier R. and Schenk S. (1993) Effects of serotonergic manipulations on cocaine self-administration in rats. Psychopharmacology (Berl.) 110, 390–394.
Prisco S. and Esposito E. (1995) Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area. Br. J. Pharmacol. 116, 1923–1931.
Richardson N. R. and Roberts D. C. (1991) Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sci. 49, 833–840.
Rocha B., Fumagalli F., Gainetdinov R., Jones S., Ator R., Giros B., et al. (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nat. Neurosci. 1, 132–137.
Romualdi P., D’Addario C., Ferri S., Cox B. M., and Izenwasser S. (2001) Chronic GBR 12909 administration differentially alters prodynorphin gene expression compared to cocaine. Eur. J. Pharmacol. 413, 207–212.
Romualdi P., Donatini A., Izenwasser S., Cox B. M., and Ferri S. (1996) Chronic intracerebroventricular cocaine differentially affects prodynorphin gene expression in rat hypothalamus and caudate putamen. Mol. Brain Res. 40, 153–156.
Sanders-Bush E., Bushing J. A., and Sulser F. (1975) Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms. J. Pharmacol. Exp. Ther. 192, 33–41.
Smiley P. L., Johnson M., Bush L., Gibb J. W., and Hanson G. R. (1990) Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharmacol. Exp. Ther. 253, 938–943.
Spangler R., Unterwald E. M., and Kreek M. J. (1993) ‘Binge’ cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Mol. Brain Res. 19, 323–327.
Spangler R., Zhou Y., Maggos C. E., Schlussman S. D., Ho A., and Kreek M. J. (1997) Prodynorphin, proenkephalin and kappa opioid receptor mRNA responses to acute “binge” cocaine. Brain Res. Mol. Brain Res. 44, 139–142.
Spangler R., Zhou Y., Maggos C. E., Zlobin A., Ho A., and Kreek M. J. (1996) Dopamine antagonist and “binge” cocaine effects on rat opioid and dopamine transporter mRNAs. NeuroReport. 7, 2196–2200.
Sprague J. E., Johnson M. P., Schmidt C. J., and Nichols D. E. (1996) Studies on the mechanism of p-chloroamphetamine neurotoxicity. Biochem. Pharmacol. 52, 1271–1277
Steranka L. R. and Sanders-Bush E. (1978) Long-term reduction of brain serotonin by p-chloroamphetamine: effects of inducers and inhibitors of drug metabolism. J. Pharmacol. Exp. Ther. 206, 460–467.
Steinbush H. V. M. Serotonin-immunoreactive neurones and their projections in the CNS, in: Bjorklund A., Hokfelt T., eds. Classical Transmitters Receptors in the CNS. Part II. Handbook of Chemical Neuroanatomy, 3, Elsevier, Amsterdam, 1984, pp. 68–90.
Steiner H. and Gerfen C. R. (1993) Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13, 5066–5081.
Tran-Nguyen L. T., Baker D. A., Grote K. A., Solano J., and Neisewander J. L. (1999) Serotonin depletion attenuates cocaine-seeking behavior in rats. Psychopharmacology (Berl.) 146, 60–66.
Tran-Nguyen L. T., Bellew J. G., Grote K. A., and Neisewander J. L. (2001) Serotonin depletion attenuates cocaine seeking but enhances sucrose seeking and the effects of cocaine priming on reinstatement of cocaine seeking in rats. Psychopharmacology (Berl.) 157, 340–348.
Turchan J., Przewlocka B., Lason W., and Przewlocki R. (1998) Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain. Neuroscience 85, 1051–1059.
Turchan J., Przewlocka B., Toth G., Lason W., and Borsodi A. (1999) The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat. Neuroscience 91, 971–977.
Uhl G. R., Hall F. S., and Sora I. (2002) Cocaine, reward, movement and monoamine transporters. Mol. Psychiatry 7, 21–26.
Unterwald E. M., Horne-King J., and Kreek M. J. (1992) Chronic cocaine alters brain mu opioid receptors. Brain Res. 584, 314–318.
Unterwald E. M., Rubenfeld J. M., and Kreek M. J. (1994) Repeated cocaine administration upregulates κ and μ, but not σ, opioid receptors. NeuroReport 5, 1613–1616.
Ward R. P. and Dorsa D. M. (1996) Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C and 5-HT6 with neuropeptides in rat striatum. J. Comp. Neurol. 370, 405–414.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Di Benedetto, M., D’Addario, C., Collins, S. et al. Role of serotonin on cocaine-mediated effects on prodynorphin gene expression in the rat brain. J Mol Neurosci 22, 213–222 (2004). https://doi.org/10.1385/JMN:22:3:213
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:22:3:213